StocksMedium•10 November 2026•
1 min read
Intelligent Bio Solutions Reports Record Fiscal Q1 2027 Revenue
Key Facts
1Intelligent Bio Solutions reported record fiscal first quarter 2027 revenue of $1.39 million.
2Revenue grew 25% year-over-year and 21% sequentially.
Intelligent Bio Solutions reported record fiscal first quarter 2027 revenue of $1.39 million. GlobeNewswire reported that revenue grew 25% year-over-year and 21% sequentially, marking the company's sixth consecutive quarter of year-over-year growth.
The results represent the third consecutive quarter with revenue exceeding $1 million, driven by the commercialization of its bio-diagnostic technologies. INBS closed at $2.29 on November 9, 2026, with a daily trading range between $2.01 and $2.35.